Showing 1 - 20 results of 38 for search 'Jérôme De Sèze', query time: 0.07s
Refine Results
-
1
Current and future treatment approaches for neuromyelitis optica by Nicolas Collongues, Jérôme de Seze
Published 2011-03-01
Article -
2
-
3
CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention by Susana Brun, Jérôme de Sèze, Sylviane Muller
Published 2022-01-01
Article -
4
A Case of Paraneoplastic Demyelinating Motor Polyneuropathy by Sohrab Mostoufizadeh, Maryam Souri, Jérôme de Seze
Published 2012-04-01
Article -
5
-
6
-
7
-
8
-
9
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic by Jérôme de Sèze, Jérôme de Sèze, Elisabeth Maillart, Elisabeth Maillart, Antoine Gueguen, David A. Laplaud, Laure Michel, Laure Michel, Laure Michel, Eric Thouvenot, Eric Thouvenot, Hélène Zephir, Luc Zimmer, Damien Biotti, Roland Liblau, Roland Liblau
Published 2023-03-01
Article -
10
-
11
-
12
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study by Romain Marignier, David Laplaud, Hélène Zéphir, Caroline Papeix, Emmanuelle Leray, Ekbel Amri, Mickaël Piotaix, Jérôme de Sèze
Published 2024-01-01
Article -
13
-
14
-
15
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis by Jerome de Seze, Dominique Dive, Xavier Ayrignac, Giovanni Castelnovo, Marianne Payet, Amel Rayah, Claudio Gobbi, Patrick Vermersch, Chiara Zecca
Published 2024-04-01
Article -
16
Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis by Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, Jerome De Sèze, Patrick Vermersch, Ali-Frederic Ben-Amor, Carine Savarin, Gilles Defer
Published 2023-11-01
Article -
17
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France by Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Published 2024-03-01
Article -
18
Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype by Bruno Brochet, Pierre Clavelou, Gilles Defer, Jérôme De Seze, Céline Louapre, Eloi Magnin, Aurélie Ruet, Catherine Thomas-Anterion, Patrick Vermersch
Published 2022-01-01
Article -
19
Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection by Valérie Jolivel, Susana Brun, Fabien Binamé, Jérémie Benyounes, Omar Taleb, Dominique Bagnard, Jérôme De Sèze, Christine Patte-Mensah, Ayikoe-Guy Mensah-Nyagan
Published 2021-03-01
Article -
20
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003) by Nicolas Collongues, Jens Kuhle, Charidimos Tsagkas, Julien Lamy, Nicolas Meyer, Christian Barro, Katrin Parmar, Michael Amann, Jens Wuerfel, Ludwig Kappos, Thibault Moreau, Jerome deSeze
Published 2021-02-01
Article